Retatrutide is a peptide under study for its simultaneous agonism at GLP-1, GIP, and glucagon receptors. Research examines its effects on body weight, glucose regulation, lipid handling, and energy expenditure in metabolic models.
Retatrutide 15mg
$90.00
Retatrutide is investigated as a multi-receptor agonist targeting GLP-1, GIP, and glucagon pathways.
33 in stock
| Test Report |
|---|
